- Home
- CVRX vs CTW Comparison
CVRX vs CTW Comparison
Compare CVRX & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- CTW
- Stock Information
- Founded
- CVRX 2000
- CTW 2013
- Country
- CVRX United States
- CTW Japan
- Employees
- CVRX N/A
- CTW N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CTW EDP Services
- Sector
- CVRX Health Care
- CTW Technology
- Exchange
- CVRX Nasdaq
- CTW Nasdaq
- Market Cap
- CVRX 203.9M
- CTW 171.4M
- IPO Year
- CVRX 2021
- CTW 2025
- Fundamental
- Price
- CVRX $7.87
- CTW $1.92
- Analyst Decision
- CVRX Buy
- CTW
- Analyst Count
- CVRX 7
- CTW 0
- Target Price
- CVRX $14.00
- CTW N/A
- AVG Volume (30 Days)
- CVRX 177.7K
- CTW 69.2K
- Earning Date
- CVRX 10-28-2025
- CTW 01-01-0001
- Dividend Yield
- CVRX N/A
- CTW N/A
- EPS Growth
- CVRX N/A
- CTW N/A
- EPS
- CVRX N/A
- CTW N/A
- Revenue
- CVRX $54,652,000.00
- CTW $76,194,020.00
- Revenue This Year
- CVRX $11.32
- CTW N/A
- Revenue Next Year
- CVRX $18.58
- CTW N/A
- P/E Ratio
- CVRX N/A
- CTW $45.23
- Revenue Growth
- CVRX 23.11
- CTW 8.71
- 52 Week Low
- CVRX $4.30
- CTW $1.71
- 52 Week High
- CVRX $18.55
- CTW $4.88
- Technical
- Relative Strength Index (RSI)
- CVRX 53.22
- CTW N/A
- Support Level
- CVRX $7.22
- CTW N/A
- Resistance Level
- CVRX $8.35
- CTW N/A
- Average True Range (ATR)
- CVRX 0.38
- CTW 0.00
- MACD
- CVRX 0.03
- CTW 0.00
- Stochastic Oscillator
- CVRX 57.52
- CTW 0.00
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.